This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Corteva, Inc. provides agriculture products. The company develops and supplies germplasm and traits in corn, soybean and sunflower seed markets. It also supplies products to the agricultural input industry which protect against weeds, insects and other pests, and diseases as well as to enhance crop health. Corteva, Inc. is based in Wilmington, Delaware.
Should iShares Russell MidCap Value ETF (IWS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWS
Corteva, Inc. (CTVA) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Corteva, Inc. (CTVA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Post Holdings (POST) Queued for Q3 Earnings: Things to Note
by Zacks Equity Research
Post Holdings' (POST) Q3 performance is likely to reflect adverse impacts from higher raw material, freight and manufacturing costs. Also, supply chain disruptions might be a concern.
Is Molson Coors (TAP) Slated to Report Earnings Beat in Q2?
by Zacks Equity Research
Molson Coors' (TAP) Q2 results are expected to reflect gains from innovation and premiumization efforts, aiding the top line. Elevated marketing and supply-chain costs are likely to have ailed.
Medifast (MED) Readies for Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Medifast's (MED) second-quarter 2022 results are likely to reflect gains from its OPTAVIA lifestyle solution and coaching support system, while escalated costs might have been a concern.
What's in Store for Service Corporation (SCI) in Q2 Earnings?
by Zacks Equity Research
Service Corporation's (SCI) second-quarter 2022 results are likely to reflect higher funeral revenues, whereas elevated costs might have been a deterrent.
Factors Likely to Decide Carter's (CRI) Fate in Q2 Earnings
by Zacks Equity Research
Carter's (CRI) second-quarter results are likely to reflect the impacts of weak retail sales, high freight costs and supply chain issues. However, online strength and improved price realization act as upsides.
Corteva, Inc. (CTVA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Corteva, Inc. (CTVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Church & Dwight (CHD) Queued for Q2 Earnings: Things to Note
by Zacks Equity Research
Church & Dwight's (CHD) second-quarter performance will likely reflect gains from solid brands and buyouts. However, rising inflation might have been a headwind.
Factors Likely to Decide Newell's (NWL) Fate in Q2 Earnings
by Zacks Equity Research
Higher costs, inflationary pressure and supply-chain woes are likely to have hurt Newell's (NWL) Q2 performance. Online strength, strong demand and core sales growth are likely to have aided.
Factors to Influence Procter & Gamble (PG) in Q4 Earnings
by Zacks Equity Research
Procter & Gamble's (PG) Q4 results are expected to reflect gains from strong demand for cleaning products and improved productivity, amid rising input costs and supply- chain woes.
Factors to Decide the Fate of Colgate (CL) in Q2 Earnings
by Zacks Equity Research
Colgate's (CL) Q2 results are expected to reflect gains from strong consumer demand, innovation, premiumization, digital growth and robust pricing actions amid rising raw material and logistic costs.
Here's How FEMSA (FMX) is Poised Just Ahead of Q2 Earnings
by Zacks Equity Research
FEMSA's (FMX) Q2 results are expected to reflect gains from strength across businesses, owing to effective growth strategies and robust demand across markets amid supply-chain and inflation woes.
Zacks.com featured highlights LPL Financial, Dollar Tree, Lamb Weston, M&T Bank and Corteva
by Zacks Equity Research
LPL Financial, Dollar Tree, Lamb Weston, M&T Bank and Corteva have been highlighted in this Screen of The Week article.
Corteva, Inc. (CTVA) Stock Moves -0.02%: What You Should Know
by Zacks Equity Research
In the latest trading session, Corteva, Inc. (CTVA) closed at $55.46, marking a -0.02% move from the previous day.
Hershey (HSY) Queues Up for Q2 Earnings: What to Expect?
by Zacks Equity Research
Hershey's (HSY) second-quarter 2022 results are likely to reflect gains from pricing and acquisitions, whereas elevated costs are likely to have been a concern.
Altria Group (MO) Readies for Q2 Earnings: What to Expect?
by Zacks Equity Research
Altria Group's (MO) second-quarter 2022 results are likely to reflect gains from pricing and strength in oral tobacco products, whereas elevated costs are likely to have been a concern.
Top 5 Low-Beta Stocks to Stay Safe From Near-Term Volatility
by Nalak Das
We have narrowed our search to five low-beta stocks. These are: LPLA, DLTR, MTB, LW and CTVA.
What's in the Offing for Pilgrim's Pride (PPC) in Q2 Earnings?
by Zacks Equity Research
Pilgrim's Pride's (PPC) Q2 performance is likely to reflect the growing Mexico business. Strength in U.S. business owing to foodservice and retail demand might have also been a tailwind.
Things You Need to Know Before Keurig's (KDP) Q2 Earnings
by Zacks Equity Research
Keurig's (KDP) Q2 results are likely to reflect solid demand, and in-market performance across categories and brands. Inflationary costs and supply-chain woes are likely to have hurt.
Kraft Heinz (KHC) Readies for Q2 Earnings: What to Expect?
by Zacks Equity Research
Kraft Heinz's (KHC) second-quarter 2022 results are likely to reflect rising cost concerns, whereas robust pricing is likely to have aided the company.
Things to Note as Lamb Weston (LW) Lines Up for Q4 Earnings
by Zacks Equity Research
Lamb Weston's (LW0 fourth-quarter fiscal 2022 results are likely to reflect gains from pricing and recovering foodservice demand amid rising cost concerns.
Here's Why Archer Daniels (ADM) is Poised for Q2 Earnings Beat
by Zacks Equity Research
Despite supply-chain issues and inflation, Archer Daniels' (ADM) Q2 results are likely to reflect gains from solid demand, a strong Nutrition segment and efforts to expand its solutions portfolio.
Things to Note as Kimberly-Clark (KMB) Lines Up for Q2 Earnings
by Zacks Equity Research
Kimberly-Clark's (KMB) second-quarter 2022 results are likely to reflect elevated input costs, while pricing and saving efforts are likely to have aided the company.
Things to Note as Mondelez (MDLZ) Lines Up for Q2 Earnings
by Zacks Equity Research
Mondelez International's (MDLZ) second-quarter 2022 results are likely to reflect elevated costs and supply-chain headwinds, while pricing and emerging market strength are likely to haveshould aided the company.